<div id="readability-page-1"><p>Old West Investment Management LLC grew its stake in  Bruker Corporation (NASDAQ:BRKR - Free Report) by 144.2% in the 3rd quarter, according to its most recent disclosure with the Securities &amp; Exchange Commission. The firm owned 573,462 shares of the medical research company's stock after buying an additional 338,618 shares during the quarter. Bruker accounts for about  4.3% of Old West Investment Management LLC's investment portfolio, making the stock its 4th biggest holding. Old West Investment Management LLC owned about 0.38% of Bruker worth $18,632,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p><p>Several other large investors also recently made changes to their positions in the stock. Hantz Financial Services Inc. lifted its position in  Bruker by 774.8% in the 3rd quarter. Hantz Financial Services Inc. now owns 13,647 shares of the medical research company's stock valued at $443,000 after acquiring an additional 12,087 shares in the last quarter.  Atlantic Union Bankshares Corp acquired a new stake in shares of  Bruker in the 3rd quarter valued at about $188,000.  Jones Financial Companies Lllp lifted its holdings in shares of  Bruker by 79.7% in the third quarter. Jones Financial Companies Lllp now owns 2,773 shares of the medical research company's stock valued at $86,000 after purchasing an additional 1,230 shares in the last quarter.  Ballast Asset Management LP boosted its position in shares of  Bruker by 31.4% during the third quarter. Ballast Asset Management LP now owns 69,364 shares of the medical research company's stock worth $2,254,000 after buying an additional 16,564 shares during the period.  Finally, AlphaQuest LLC grew its holdings in shares of  Bruker by 204.6% during the third quarter. AlphaQuest LLC now owns 11,167 shares of the medical research company's stock worth $363,000 after buying an additional 7,501 shares in the last quarter. Institutional investors own  79.52% of the company's stock. </p><h2>Insider Activity</h2><p>In other news, VP Mark Munch sold 2,000 shares of Bruker stock in a transaction that occurred on Thursday, January 15th. The stock was sold at an average price of $49.20, for a total transaction of $98,400.00. Following the completion of the transaction, the vice president directly owned 128,443 shares in the company, valued at approximately $6,319,395.60. The trade was a 1.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 27.30% of the stock is currently owned by insiders. </p><h2>Analysts Set New Price Targets</h2><p>A number of equities analysts have weighed in on the company. UBS Group upped their price target on Bruker from $40.00 to $43.00 and gave the stock a &#34;neutral&#34; rating in a research report on Tuesday, November 4th. The Goldman Sachs Group assumed coverage on shares of Bruker in a report on Tuesday, December 9th. They set a &#34;sell&#34; rating and a $40.00 target price for the company. Bank of America raised their target price on shares of Bruker from $43.00 to $60.00 and gave the company a &#34;buy&#34; rating in a research report on Monday, December 15th. Zacks Research raised shares of Bruker from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Monday, December 8th. Finally, Wells Fargo &amp; Company increased their price objective on shares of Bruker from $48.00 to $55.00 and gave the stock an &#34;overweight&#34; rating in a research note on Monday, December 15th. One investment analyst  has rated the stock with a Strong Buy rating, seven have assigned  a Buy rating, five have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Bruker currently has a consensus rating of &#34;Hold&#34; and an average target price of $53.23.</p><p><b>Get Our Latest Research Report on BRKR</b></p><h2>Bruker Stock Performance</h2><p>Shares of BRKR opened at $41.93 on Friday. The company has a market cap of $6.37 billion, a PE ratio of -262.06, a price-to-earnings-growth ratio of 5.40 and a beta of 1.19. The firm has a 50-day moving average of $47.71 and a 200-day moving average of $40.53. Bruker Corporation has a one year low of $28.53 and a one year high of $56.48. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.85 and a quick ratio of 0.91. </p><h2>Bruker Profile</h2> (Free Report)<p>Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.  </p><p>Bruker's product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.  </p><p>In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Bruker</li><li>NEW LAW: Congress Approves Setup For Digital Dollar?</li><li>The day the gold market broke</li><li>What a Former CIA Agent Knows About the Coming Collapse</li><li>Your Bank Account Is No Longer Safe</li><li>He just nailed another gold prediction …</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QlJLUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QlJLUg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Bruker Right Now?</h2><p>Before you consider Bruker, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bruker wasn't on the list.</p><p>While Bruker currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

SBIO

BRKR

<p>Old West Investment Management LLC increased its stake in Bruker Corporation (NASDAQ:BRKR) by 144.2% in Q3, acquiring 338,618 shares, bringing its total to 573,462 shares. This investment represents 4.3% of its portfolio, valued at approximately $18.6 million. Other investors also adjusted their positions, with significant increases from Hantz Financial Services and AlphaQuest LLC. Analysts have varied opinions on Bruker, with price targets ranging from $40 to $60. The stock opened at $41.93, with a market cap of $6.37 billion and a consensus rating of "Hold."</p>

Market Beat

First Trust NYSE Arca Biotech Index Fd

Proshares Ultra Nasdaq Biotech

ALPS Medical Breakthrough

Invesco Biotechnology & Genome ETF

Bruker

SPDR S&P Health Equip

iShares Biotechnology ETF

VanEck Biotech ETF

SPDR S&P Biotech

iShares US Medical Devices

Old West Investment Management LLC Buys 338,618 Shares of Bruker Corporation $BRKR